Skip to content

Public FDA record

Z-0738-2008: Optiflux 180NR Advanced Fresenius Polysulfone, Catalog No.: 0500318E, Fresenius Medical Care North Americ

Recall record Z-0738-2008 for Fresenius Medical Care North America. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0738-2008
Company in FDA record
Fresenius Medical Care North America
FDA classification date
Feb 1, 2008
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Leaking: the Dialyzer may leak at the header resulting in small amounts of blood loss.

Source facts

Action
Consignees were notified by telephone and certified letter , Urgent Device Recall, on 12/03/2007. They were told to discontinue use and to return all unused affected dialyzers to Fresenius.
Initiated
2007-12-03
Root cause
Process control
Terminated
2008-02-08
Distribution
Nationwide including the states of AZ, CA, HI, IA, ID, IL, IN, KS, KY, MI, MN, MO, NE, NV, NY, OH, OR, PA, WA, and WI.
Recall number
Z-0738-2008
Recall status
Terminated
CDRH record ID
67161
FDA classified
2008-02-01
Recall event number
46292

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗